<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03543384</url>
  </required_header>
  <id_info>
    <org_study_id>6810</org_study_id>
    <nct_id>NCT03543384</nct_id>
  </id_info>
  <brief_title>Imaging of Facial Neuritis</brief_title>
  <official_title>Imaging of Facial Neuritis Using T2-weighted Gradient-echo Fast Imaging Employing Steady State Acquisition After Gadolinium Injection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Improved means of positive diagnosis of facial neuritis, the leading cause of peripheral
      facial palsy
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">February 20, 2018</start_date>
  <completion_date type="Anticipated">February 2019</completion_date>
  <primary_completion_date type="Anticipated">February 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Presence or absence of pathologic enhancement of the facial nerve on the symptomatological side of the T2 sequence (FIESTA-C)</measure>
    <time_frame>1 hour after the realization of the MRI</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Facial Neuritis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with neuritis facial (neuritis group) who benefited, between 2009 and 2016, from
        an MRI of the internal auditory ducts, with gadolinous product injection and on the MRI 3
        Tesla
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18-80 years

          -  Subject giving their consent for their participation

          -  Patients with neuritis facial (neuritis group) who benefited, between 2009 and 2016,
             from an MRI of the internal auditory ducts, with gadolinous product injection and on
             the MRI 3 Tesla

          -  Patients with a perception deafness, without neuritis sign (control group) who also
             benefited from an MRI with gadolinous product injection on the MRI 3T with the same
             protocol.

        Exclusion Criteria:

        - Refusal to participate in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Francis VEILLON, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Strasbourg, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Francis VEILLON, MD, PhD</last_name>
    <phone>33 3 88 12 78 65</phone>
    <email>Francis.veillon@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Aïna VENKATASAMY, MD</last_name>
    <phone>33 3 88 12 78 65</phone>
    <email>aina.venkatasamy@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service Imagerie 1</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francis VEILLON, MD, PhD</last_name>
      <phone>33 3 88 12 78 65</phone>
      <email>Francis.veillon@chru-strasbourg.fr</email>
    </contact>
    <contact_backup>
      <last_name>Aïna VENKATASAMY, MD, PhD</last_name>
      <phone>33 3 88 12 78 65</phone>
      <email>aina.venkatasamy@chru-strasbourg.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Francis VEILLON, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aïna VENKATASAMY, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <study_first_submitted>February 26, 2018</study_first_submitted>
  <study_first_submitted_qc>May 31, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 1, 2018</study_first_posted>
  <last_update_submitted>May 31, 2018</last_update_submitted>
  <last_update_submitted_qc>May 31, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>facial neuritis</keyword>
  <keyword>T2 weighted gradient-echo</keyword>
  <keyword>fast imaging employing steady state acquisition (FIESTA-C)</keyword>
  <keyword>magnetic resonance imaging (MRI)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Facial Nerve Diseases</mesh_term>
    <mesh_term>Neuritis</mesh_term>
    <mesh_term>Facies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

